Mutsumi Ito

9.4k total citations · 1 hit paper
56 papers, 1.2k citations indexed

About

Mutsumi Ito is a scholar working on Epidemiology, Infectious Diseases and Agronomy and Crop Science. According to data from OpenAlex, Mutsumi Ito has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 31 papers in Infectious Diseases and 10 papers in Agronomy and Crop Science. Recurrent topics in Mutsumi Ito's work include Influenza Virus Research Studies (33 papers), Respiratory viral infections research (24 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). Mutsumi Ito is often cited by papers focused on Influenza Virus Research Studies (33 papers), Respiratory viral infections research (24 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). Mutsumi Ito collaborates with scholars based in Japan, United States and Vietnam. Mutsumi Ito's co-authors include Yoshihiro Kawaoka, Maki Kiso, Seiya Yamayoshi, Chiharu Kawakami, Ryuta Uraki, Norio Sugaya, Masataka Ichikawa, Keiko Mitamura, Kazuhiro Kimura and Shuji Hatakeyama and has published in prestigious journals such as Nature, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Mutsumi Ito

53 papers receiving 1.1k citations

Hit Papers

A human isolate of bovine H5N1 is transmissible and letha... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mutsumi Ito Japan 19 911 413 268 197 191 56 1.2k
Matthew Angel United States 20 930 1.0× 471 1.1× 479 1.8× 268 1.4× 300 1.6× 31 1.4k
Troy C. Sutton United States 20 868 1.0× 546 1.3× 271 1.0× 374 1.9× 183 1.0× 40 1.2k
Mamadou Dramé Belgium 17 1.2k 1.3× 525 1.3× 509 1.9× 221 1.1× 186 1.0× 33 1.4k
Angela Choi United States 14 711 0.8× 304 0.7× 409 1.5× 76 0.4× 174 0.9× 23 1.0k
Siu-Ying Lau Hong Kong 15 633 0.7× 304 0.7× 211 0.8× 248 1.3× 202 1.1× 25 830
Irina Isakova–Sivak Russia 20 834 0.9× 388 0.9× 342 1.3× 152 0.8× 165 0.9× 76 998
Quanjiao Chen China 20 816 0.9× 484 1.2× 261 1.0× 375 1.9× 329 1.7× 53 1.2k
Hyeok-Il Kwon South Korea 19 736 0.8× 597 1.4× 143 0.5× 381 1.9× 182 1.0× 51 1.2k
Rebecca L. Dunfee United States 13 629 0.7× 477 1.2× 472 1.8× 103 0.5× 264 1.4× 13 1.3k
Kortney M. Gustin United States 20 1.2k 1.3× 505 1.2× 296 1.1× 488 2.5× 123 0.6× 26 1.4k

Countries citing papers authored by Mutsumi Ito

Since Specialization
Citations

This map shows the geographic impact of Mutsumi Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mutsumi Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mutsumi Ito more than expected).

Fields of papers citing papers by Mutsumi Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mutsumi Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mutsumi Ito. The network helps show where Mutsumi Ito may publish in the future.

Co-authorship network of co-authors of Mutsumi Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Mutsumi Ito. A scholar is included among the top collaborators of Mutsumi Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mutsumi Ito. Mutsumi Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uraki, Ryuta, Mutsumi Ito, Maki Kiso, et al.. (2025). An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters. PubMed. 3(1). 7–7.
2.
Uraki, Ryuta, Maki Kiso, Mutsumi Ito, et al.. (2025). An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant. EBioMedicine. 117. 105794–105794. 1 indexed citations
3.
Uraki, Ryuta, Masaki Imai, Mutsumi Ito, et al.. (2024). An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants. npj Vaccines. 9(1). 4–4. 7 indexed citations
4.
Hagihara, Masao, Tomoyuki Uchida, Yuko Sakai‐Tagawa, et al.. (2024). Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies. Internal Medicine. 63(16). 2283–2287. 2 indexed citations
5.
Halfmann, Peter, Kiyoko Iwatsuki‐Horimoto, Makoto Kuroda, et al.. (2024). Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters. Communications Biology. 7(1). 331–331. 6 indexed citations
6.
Kiso, Maki, Ryuta Uraki, Mutsumi Ito, et al.. (2023). Oral intake of heat-killed Lactiplantibacillus pentosus ONRICb0240 partially protects mice against SARS-CoV-2 infection. SHILAP Revista de lepidopterología. 3. 2 indexed citations
7.
Braun, Katarina M., Luis A. Haddock, Chelsea M. Crooks, et al.. (2023). Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammals. Virus Evolution. 9(1). vead004–vead004. 4 indexed citations
8.
Iwatsuki‐Horimoto, Kiyoko, Hiroshi Ueki, Mutsumi Ito, et al.. (2023). SARS-CoV-2 Transmission from Virus-Infected Dead Hamsters. mSphere. 8(1). e0041122–e0041122.
9.
Chiba, S., Maki Kiso, Noriko Nakajima, et al.. (2022). Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model. mBio. 13(1). e0304421–e0304421. 23 indexed citations
10.
Uraki, Ryuta, Masaki Imai, Mutsumi Ito, et al.. (2021). Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens. PLoS Pathogens. 17(12). e1010085–e1010085. 15 indexed citations
11.
Takamatsu, Yuki, Masaki Imai, Kenji Maeda, et al.. (2021). Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters. Journal of Virology. 96(4). e0155121–e0155121. 16 indexed citations
12.
Ohtsuka, Junpei, Masaki Imai, Masayuki Fukumura, et al.. (2021). Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2. iScience. 24(12). 103379–103379. 13 indexed citations
13.
Sakai‐Tagawa, Yuko, Makoto Yamashita, Kiyoko Iwatsuki‐Horimoto, et al.. (2020). Antigenic variants of influenza B viruses isolated in Japan during the 2017‐2018 and 2018‐2019 influenza seasons. Influenza and Other Respiratory Viruses. 14(3). 311–319. 7 indexed citations
14.
Watanabe, Tokiko, Kiyoko Iwatsuki‐Horimoto, Maki Kiso, et al.. (2018). Experimental infection of Cynomolgus Macaques with highly pathogenic H5N1 influenza virus through the aerosol route. Scientific Reports. 8(1). 4801–4801. 9 indexed citations
15.
Wu, Nicholas C., Seiya Yamayoshi, Mutsumi Ito, et al.. (2018). Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene. Cell Host & Microbe. 24(4). 569–578.e4. 33 indexed citations
16.
Yamayoshi, Seiya, Atsuhiro Yasuhara, Mutsumi Ito, Ryuta Uraki, & Yoshihiro Kawaoka. (2018). Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus. Journal of Clinical Virology. 108. 105–111. 13 indexed citations
17.
Yasuhara, Atsuhiro, Seiya Yamayoshi, Chiharu Kawakami, et al.. (2017). Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies. Scientific Reports. 7(1). 17735–17735. 20 indexed citations
18.
Iwatsuki‐Horimoto, Kiyoko, Noriko Nakajima, Masatoshi Shibata, et al.. (2016). The Microminipig as an Animal Model for Influenza A Virus Infection. Journal of Virology. 91(2). 18 indexed citations
19.
Sugaya, Norio, Keiko Mitamura, Masahiko Yamazaki, et al.. (2006). Lower Clinical Effectiveness of Oseltamivir against Influenza B Contrasted with Influenza A Infection in Children. Clinical Infectious Diseases. 44(2). 197–202. 131 indexed citations
20.
Horimoto, Taisuke, Ayato Takada, Ken Fujii, et al.. (2005). The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine. 24(17). 3669–3676. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026